Rtw Investments, LP Akero Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.51 Billion
- Q2 2025
A detailed history of Rtw Investments, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 5,477,561 shares of AKRO stock, worth $263 Million. This represents 4.49% of its overall portfolio holdings.
Number of Shares
5,477,561
Previous 7,419,340
26.17%
Holding current value
$263 Million
Previous $300 Million
2.68%
% of portfolio
4.49%
Previous 4.92%
Shares
6 transactions
Others Institutions Holding AKRO
# of Institutions
296Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$324 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$275 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$268 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$218 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.51MShares$217 Million0.03% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.23B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...